ADE LLC’s Abbott ABT Stock Holding History

ADE LLC’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-138	Closed	-$16K	–	84
2021 Q3	$16K	Hold	138	–	–	0.01%	180
2021 Q2	$16K	Hold	138	–	–	0.01%	192
2021 Q1	$17K	Hold	138	–	–	0.02%	174
2020 Q4	$15K	Buy	+138	New	+$15K	0.01%	244

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ADE LLC's ABT Position: Q4 2021 in Review

ADE LLC sold out of Abbott (ABT) in Q4 2021, closing a stake of 138 shares — an estimated $16K sold.

ADE LLC first reported a position in ABT in Q4 2020 and held it in 4 quarters. The position peaked at $17K in Q1 2021. 2,812 funds tracked by Wall St. Rank hold ABT as of Q4 2021.

ADE LLC reported no remaining Abbott position as of Q4 2021 after selling out during the quarter.
ADE LLC sold 138 Abbott shares in Q4 2021, an estimated $16K.
ADE LLC first reported a position in Abbott in Q4 2020 and held it in 4 quarters.
ADE LLC's Abbott position peaked at $17K in Q1 2021.
2,812 funds tracked by Wall St. Rank held Abbott as of Q4 2021.

Based on ADE LLC's 13F filing for Q4 2021, filed 14 Feb 2022.